This is not the most recent version of the article. View current version (9 NOV 2011)

Intervention Protocol

Antiplatelet agents for intermittent claudication

  1. Peter Robless1,*,
  2. Dimitris P Mikhailidis2,
  3. Gerard P Stansby3

Editorial Group: Cochrane Peripheral Vascular Diseases Group

Published Online: 21 JAN 2009

DOI: 10.1002/14651858.CD001272

How to Cite

Robless P, Mikhailidis DP, Stansby GP. Antiplatelet agents for intermittent claudication (Protocol). Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD001272. DOI: 10.1002/14651858.CD001272.

Author Information

  1. 1

    Yong Loo Lin School of Medicine, National University of Singapore, Department of Cardiac, Thoracic and Vascular Surgery, Singapore, Singapore

  2. 2

    Royal Free and University College Medical School, Department of Clinical Biochemistry, London, UK

  3. 3

    University of Newcastle upon Tyne, Department of Surgery, Newcastle upon Tyne, UK

*Peter Robless, Department of Cardiac, Thoracic and Vascular Surgery, Yong Loo Lin School of Medicine, National University of Singapore, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore. surrpa@nus.edu.sg. peter_robless@btopenworld.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

This is not the most recent version of the article.View current version (09 Nov 2011)

  1. Current Version

    Antiplatelet agents for intermittent claudication

    Peng F Wong, Lee Yee Chong, Dimitris P Mikhailidis, Peter Robless and Gerard Stansby

    Article first published online: 9 NOV 2011 | DOI: 10.1002/14651858.CD001272.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Antiplatelet agents for intermittent claudication

    Peter Robless, Dimitris P Mikhailidis and Gerard P Stansby

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD001272